All BPC-157 + TB-500 certificates

BPC-157 + TB-500 10 mg Certificate of Analysis Batch APL-BPCTB10-2610-05

BPC-157 + TB-500 10 mg from batch APL-BPCTB10-2610-05 was analysed on 23 October 2026 and measured 98.97% combined purity across TB-500 and BPC-157 by HPLC / Mass Spectrometry, passing all 5 release tests.

Combined purity
98.97%
Components
TB-500, BPC-157
Result
All 5 tests passed
Tested
23 October 2026
Method
HPLC / Mass Spectrometry
Net content
10.07 mg

Independent verification

BPC-157 + TB-500 10 mg is independently verified by Ozcanium Analytics, an independent Australian laboratory, at 98.29% purity by UPLC-MS/MS, analysed 27 August 2026 on lot APL-BPCTB10-2608-01, net content BPC-157 10.48 mg, TB-500 10.19 mg, verification code OZ-HPLCMS-BJ29.

Issued by Ozcanium Analytics. Covers every vial size of this compound; each report opens as the laboratory issued it.

Enter a code in the Ozcanium Analytics verification portal (opens in a new tab) to confirm the report against their own records.

The certificate as issued is reproduced below — pinch to zoom on a phone, or use Print / Save as PDF for a full-size copy.

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 1 of 3

Certificate of Analysis BPC-157 + TB-500 10 mg Batch APL-BPCTB10-2610-05
Compound Mix
BPC-157 + TB-500
Lot Number
APL-BPCTB10-2610-05
Analysis Date
23 October 2026
Method
HPLC / Mass Spectrometry
Purity
98.97%
Net Content
10.07 mg
BPC-157 + TB-500 vial
Net Content
  • TB-5005.05 mg
  • BPC-1575.10 mg
Form
Lyophilised Powder
Manufactured
October 2026
Issued
24 October 2026
Document ID
APL-COA-BPCTB10-2610-05
Verification Code
Batch traceable

High Performance Liquid Chromatography (HPLC-UV) Chromatogram

mAUPDA 214 nm018837556375022.533.544.555.56 min 2.7602.990TB-5003.224BPC-1573.4143.8865.124

Components resolved at 2.95 min (TB-500, 45.67%), 3.24 min (BPC-157, 53.22%); combined peptide area 98.89%. No single impurity peak exceeds 0.43%.

Peak List

Peaks detected: 6
#Time (min)Area% AreaAssignment
12.76024,1810.334—
22.9903,272,65045.203TB-500
33.2243,892,67553.768BPC-157
43.41425,8460.357—
53.88617,3760.240—
65.1247,0950.098—

Analytical Results

TestSpecificationResultStatus
AppearanceWhite/Off-White Lyophilised PowderConformsPASS
Identity (MS)All components confirmedConfirmedPASS
Purity (HPLC)≥98.0% combined98.97%PASS
Total Peptide Content95–105%98.7%PASS
Endotoxins<0.5 EU/mg<0.25 EU/mgPASS

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 2 of 3

TB-500

PubChem CID: 16132341 · CAS Number: 77591-33-4

Formula: C212H350N56O78S · MW: 4963.4 g/mol · In this vial: 5.05 mg

SequenceAc-SDKPDMAEIEKFDKSKLKKTETQEKNPLPSKETIEQEKQAGES (43 aa, N-terminally acetylated)

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 23 October 2026
Monitored (m/z)Detected (m/z)Relative Intensity
828827.91.45
994993.771.12
12421242.591.92

Detection assignment: TB-500

Collected Mass Spectrum

Intensity ×107

00.511.522.5500700900110013001500 m/z 8289941243

Australian Peptide Labs

In-House Analytical Laboratory

Australian Peptide Labs Pty Ltd

ABN 55 696 074 361

australianpeptidelabs.com.au

Page 3 of 3

BPC-157

PubChem CID: 9941957 · CAS Number: 137525-51-0

Formula: C62H98N16O22 · MW: 1419.5 g/mol · In this vial: 5.10 mg

SequenceGEPPPGKPADDAGLV

Liquid Chromatography Mass Spectrometry (LC-MS) Identity Analysis

Identity confirmation with SIM

Analysis date: 23 October 2026
Monitored (m/z)Detected (m/z)Relative Intensity
474474.340.96
711710.473.42
14211420.791.37

Detection assignment: BPC-157

Collected Mass Spectrum

Intensity ×107

01234020040060080010001200140016001800 m/z 4747101421

Verification Protocol

  • Identity confirmed separately for each component by mass spectrometry against its own expected ion channels.
  • Purity measured by HPLC as the combined area of every assigned component peak against all integrated impurity peaks.
  • Batch traceability: this document reports the lot number printed on the vial.
  • Analysis performed in-house by Australian Peptide Labs.

Supplied for laboratory research use only. Not a therapeutic good; not for human or veterinary use.

View BPC-157 + TB-500 in the catalogueHow to read this certificate